At two consecutive 'checkpoints' in their development, T cells have to be rescued from programmed cell death and to choose between distinct lineage fates; recent results show that the Notch transmembrane receptor can significantly influence T-cell development at both of these points. As lymphocytes develop from pluripotent stem cells, in order to survive and mature they need to productively rearrange their antigen-receptor genes, which are present in pieces in the germ-line genome. Several 'checkpoints' have been identified at which developing T and B lymphocytes have to make a particular type of receptor in order to proceed to the next developmental stage. In the case of T cells, not only whether they will survive but also which particular lineage they will follow is determined at these checkpoints.
As lymphocytes develop from pluripotent stem cells, in order to survive and mature they need to productively rearrange their antigen-receptor genes, which are present in pieces in the germ-line genome. Several 'checkpoints' have been identified at which developing T and B lymphocytes have to make a particular type of receptor in order to proceed to the next developmental stage. In the case of T cells, not only whether they will survive but also which particular lineage they will follow is determined at these checkpoints.
T-cell receptors come in two main kinds, ␣␤ and ␥␦, both heterodimers; ␣␤ and ␥␦ T cells have distinct properties, however, so that the two lineages can be defined independently of the particular type of receptor expressed (see below). Early in the T-cell lineage, ␥, ␦ and ␤ T-cell receptor genes are rearranged (Fig. 1) . If the ␥ and ␦ genes are rearranged productively -the component parts being joined in the correct reading frame -then the cells express a ␥␦ T-cell receptor at the surface and subsequently follow the ␥␦ lineage. If the ␥␦ genes are not both rearranged productively, then the cells can go on and attempt to enter the ␣␤ lineage. This is consistent with the finding that there is selection against productive ␥ and ␦ gene rearrangements in ␣␤ lineage cells [1] [2] [3] It appears that the decision to become a ␥␦ T cell is not strictly determined by the type of receptor -either ␥␦ or ␣␤ -that is expressed, but rather by the timing of receptor expression. Thus, if an ␣␤ T-cell receptor is expressed abnormally early in transgenic mice, then cells are formed with properties characteristic of being on the ␥␦ lineagefor example, they crucially depend on the expression of the cytokine receptor ␥ chain [4] -but that nevertheless Early in T-cell development, the ␥, ␦ and ␤ chain T-cell receptor genes are rearranged, but the ␣ chain gene remains unrearranged. Cells that can make a ␥␦ T-cell receptor become ␥␦ lineage cells; recent results show that Notch can induce expression of CD4 and CD8 in these cells, though most may consequently turn off cell-surface ␥␦ T-cell receptor expression. Cells that cannot make a ␥␦ T-cell receptor, but that productively rearrange a ␤-chain gene, express the 'pre-T-cell receptor' -a heterodimer of a ␤ chain and a pre-T-cell receptor ␣ chain. These cells expand, rearrange their ␣ chain locus and become CD4 + CD8 + ␣␤-expressing cells; Notch supports the development of these cells. Immature CD4 + CD8 + ␣␤ + cells can be rescued from programmed cell death if their receptor binds to a class I or class II MHC molecule. Ligation of class I MHC molecules results in the formation of mature CD4 -CD8 + cells, and this pathway is promoted by Notch. Ligation of class II MHC molecules results in the formation of CD4 + CD8 -cells. Some CD4 -CD8 + cells with class II MHC specific T-cell receptors may result from the influence of an active Notch receptor.
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express ␣␤, rather than ␥␦, T-cell receptors [5] . Early expression of either ␥␦ or ␣␤ T-cell receptor transgenes does not, however, entirely block the development of ␣␤ T cells, indicating that neither the quality of the T-cell receptor nor the timing of T-cell receptor expression are the only factors determining commitment to the ␣␤ lineage [5, 6] .
Cells that enter the ␣␤ lineage first express 'pre-T-cell receptors', heterodimers of the T-cell receptor ␤ chain and the 'pre-T-cell receptor' ␣ chain (Fig. 1) . Expression of this receptor by cells with a productively-rearranged ␤-chain gene rescues them from programmed cell death, terminates further rearrangement of the ␤-, ␦-and probably also ␥-chain genes, and induces a strong wave of proliferation in the selected cells that eventually express CD4 and CD8 cell-surface molecules [7] . CD4 and CD8 are believed to be markers of the ␣␤ lineage; mature ␣␤ T cells express either CD4 or CD8, which act as coreceptors in cells specific for peptide antigens bound to, respectively, class II or class I major histocompatibility complex (MHC) molecules. Mutant mice that lack the pre-T-cell receptor ␣ chain can, however, still generate CD4 + CD8 + cells in several ways, and some of these can express bone fide ␥␦ T-cell receptors; again, therefore, the correlation between receptor type and cell phenotype is good, but not perfect [7] .
A second checkpoint in the development of ␣␤ T cells depends on the binding of the T-cell receptor to thymic MHC molecules, which can rescue immature ␣␤ T cells from programmed cell death (Fig. 1 ). This rescue is again associated with lineage commitment: depending on whether the T-cell receptor is specific for class I or class II MHC molecules, the rescued cells will have the CD4 -CD8 + cytolytic or CD4 + CD8 -helper T-cell phenotype [8] . Even here, however, there is no perfect correlation between T-cell receptor specificity and lineage commitment, because CD4 -CD8 + cytolytic T cells can be selected that express a T-cell receptor specific for class II MHC molecules [9] .
At both these checkpoints in T-cell development, the molecular mechanisms specifying cell survival and, especially, lineage commitment have been largely unknown. Two recent papers [10, 11] have now reported evidence implicating Notch as a key player in the lineage decisions at both of these checkpoints. Notch was originally identified in the fruitfly Drosophila, where, in ectodermal precursor cells, activated Notch inhibits neural differentiation so that the cells follow the alternative, epidermal fate. It appears that neighbouring precursors expressing slightly different levels of Notch and its ligand can influence each other in such a way that an initially small difference becomes exaggerated, and one cell comes to express only the receptor, and differentiates into an epidermal cell, and the other comes to express only the ligand, and differentiates into a neuron. This is thought to explain why, in mosaic fruitflies, heterozygous Notch +/-precursors -which presumably start off expressing a lower than normal level of Notch -adopt mostly the neural fate when next to wild-type precursors, but both neural and epidermal fates when developing in the absence of wild-type cells [12] . Notch homologs have been implicated in a number of different developing systems in various species. In hemopoietic cells of mammals, for example, Notch can inhibit differentiation into myeloid cells and thereby increase cell numbers of less differentiated hemopoietic precursors [13] .
The two new studies [10, 11] The caveat notwithstanding, additional data suggest that Notch does act to promote differentiation to the ␣␤ T-cell lineage. An activated form of Notch was expressed from a transgene in mice that were relatively deficient in ␣␤ lineage cells, either because they expressed ␥ and ␦ chain transgenes or because they lacked the ␤ chain as a result of a mutation. In these mice, it was found that expression of activated Notch led to an increase in the proportion of CD4 + CD8 + cells with productive ␥␦ gene rearrangements [10] . In the ␤ chain mutant mice, it was actually not clear whether there was an absolute increase in the number of CD4 + CD8 + cells with or without productive ␥␦ gene rearrangements; it did appear, however, that within the CD4 + CD8 + population there had at some point been selection for cells with in-frame ␥␦ gene rearrangements (although these cells no longer expressed ␥␦ T-cell receptors at the cell surface). Gene rearrangement was clearly relevant to the observed effect of the activated Notch, as it did not affect development in rearrangement-deficient, rag mutant mice. It was concluded from these experiments that activated Notch could force ␥␦ T-cell receptor expressing cells into the CD4 + 8 + ␣␤ lineage, so that the cells adopt an ␣␤ phenotype, even though they are carrying productively rearranged ␥-and ␦-chain genes, but not productively rearranged ␣-or ␤-chain genes.
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In the other paper, Robey et al. [11] studied the effect of expressing activated Notch on the second checkpoint in T-cell development: the point at which cells choose whether to develop into CD4 -CD8 + or CD4 + CD8 -cells. They found that expression of activated Notch increased the production of CD4 -CD8 + cells and decreased the production of CD4 + CD8 -cells. The activated Notch also caused an increase in the proportion of CD4 -CD8 + cells in class I MHC-deficient mutant mice, but not in mice deficient in expression of both class I and class II MHC molecules [11] . Robey et al. [11] concluded that Notch activity forces cells into the CD4 -CD8 + lineage, and away from the CD4 + CD8 -lineage.
Although the interpretation of these very interesting observations [10, 11] It is more difficult to explain the apparent deficit in some T-cell subsets seen in certain situations. This may reflect a competition that favours cells expressing higher levels of Notch. In the case of the wild-type-Notch +/-chimeras, for instance, one could argue that the wild-type ␣␤ lineage precursors outcompete the Notch +/-precursors, and that this is the only reason why they contribute more to the ␣␤ lineage. In the case of the CD4 -CD8 + T cells, one could argue that these cells, when expressing higher Notch levels, outcompete CD4 + CD8 -cells that express lower Notch levels soon after the lineage decision has been made. This would be consistent with the notion that Notch favours survival or expansion of some hemopoietic cells. [13] .
Thus, in a strict sense, the new data do not directly show that Notch makes lineage decisions during lymphocyte development, although they are perfectly consistent with such a notion The final word is not in on this issue, but these experiments have certainly added another level of complexity to our appreciation of lymphocyte development and lymphocyte lineage decision.
